Direct to Consumer Liquid Biopsy Test for Multiple Cancers
November 3, 2015 | Terry Sharrer
Pathway Genomics (San Diego, CA) is the first company to offer liquid biopsy screening tests for multiple cancers directly to consumers. See the Site Listing Tests . A quick, easy, and relatively inexpensive ($699 in this case) screening test could be enormously beneficial in knocking down cancer mortality by earlier diagnosis. But do Pathway Genomics’ tests accurately reveal that cancer is developing, and have they been tested sufficiently to make such claims? The second piece here raises these questions. MORE
See Critical Opinion With Video
Image Credit: Pathway Genomics